T1	Protein 55 82	tumor necrosis factor alpha
T2	Protein 290 317	tumor necrosis factor alpha
T3	Protein 319 328	TNF-alpha
T4	Protein 527 536	TNF-alpha
T5	Protein 591 600	TNF-alpha
T6	Protein 707 716	TNF-alpha
T7	Protein 782 791	TNF-alpha
T8	Protein 977 986	TNF-alpha
T9	Protein 1073 1082	TNF-alpha
T10	Protein 1332 1341	TNF-alpha
T11	Protein 1444 1453	TNF-alpha
T12	Protein 1592 1601	TNF-alpha
T13	Protein 1722 1731	TNF-alpha
T35	Exp 382 386	Sc-I
T36	Exp 136 146	Triggering
T37	Exp 1054 1062	contrast
T38	Exp 1362 1377	HLA-DR antigens
R6	Coref Anaphora:T15 Antecedent:T35
R7	Coref Anaphora:T14 Antecedent:T36
R8	Coref Anaphora:T21 Antecedent:T5
R9	Coref Anaphora:T25 Antecedent:T37
R10	Coref Anaphora:T29 Antecedent:T38
T14	Exp 509 511	it
T15	Exp 388 393	which
T16	Exp 175 221	the anti-HLA-DR monoclonal antibody (mAb) L243
T17	Exp 275 286	the release
T18	Exp 333 348	the non-Hodgkin
T19	Exp 452 494	the more mature Burkitt lymphoma cell Raji
T20	Exp 548 579	the pre-B leukemia cells Nalm-6
T21	Exp 654 656	it
T22	Exp 801 816	the enhancement
T23	Exp 914 928	the triggering
T24	Exp 951 963	the presence
T25	Exp 1194 1196	it
T26	Exp 1107 1132	the homotypic aggregation
T27	Exp 1212 1229	the proliferation
T28	Exp 1267 1275	our data
T29	Exp 1389 1400	their stage
T30	Exp 1288 1292	that
T31	Exp 1298 1309	the ability
T32	Exp 1477 1486	the stage
T33	Exp 1534 1545	the amounts
T34	Exp 1612 1622	the levels
